CleanSpace Holdings (CSX) Fair Value & Analysis
Healthcare · AU · Market cap A$28.8M
Fair value as of: Jun 25, 2026
From 8 valuation models · updated 4 days ago
Fair value updated Jun 25, 2026 — revised from A$1.05 to A$0.1300 (−87.6%) since Jun 24, 2026. Share price +6.7% over the past month.
Price vs Fair Value (12 months)
12‑month range A$0.3200 – A$0.8600 · fair‑value band A$0.0900 – A$0.1800 · the A$0.4000 price screens above the A$0.1300 fair value. As of Jun 25, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
CleanSpace Holdings (CSX) currently trades at A$0.4000, while our model-based Fair Value estimate is A$0.1300 — implying the stock looks roughly 67.5% overvalued today. We read business quality at 92/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
Over the trailing twelve months, CleanSpace Holdings generated revenue of A$20.7M at a net margin of 8.5%. Revenue grew 9.7% year over year. It earns a return on equity of 8.8%. Net debt stands at A$2.0M. Fundamentals as of Jun 25, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 25, 2026. TTM = trailing twelve months.
About the company
CleanSpace Holdings Limited designs, manufactures, and sells respirators and related products and services for people working in industrial and healthcare environments in the United Kingdom, rest of Europe, the Asia Pacific, North America, and internationally. The company offers CleanSpace HALO, which provides an elevated level of respiratory protection in healthcare environments; CleanSpace CST PRO, a technology that keeps protected and connected; CleanSpace CST ULTRA, an intelligent powered air purifying respirator (PAPR) system that provides protection reporting for safety compliance; CleanSpace EX, a PAPR for explosive atmospheres; and CleanSpace Work, an industrial PAPR for high dust environments. It also provides accessories and consumable products, such as masks, filters, and docking stations. The company was founded in 2009 and is based in St Leonards, Australia.
Revenue & earnings trend
FY2020 – FY2024 · reported fiscal years
CleanSpace Holdings reported revenue of A$19.8M in FY2024 versus A$49.9M in FY2020, a compound −20.7%/yr. Reported net income was −A$478K in FY2024.
Open the full interactive analysis →
Similar stocks
6 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Jun 25, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Abbott Laboratories, ABT | 1,600 MXN | 1,231 MXN | -23% |
| Stryker Corporation S1YK34 | R$77.83 | R$8.47 | -89% |
| Medtronic plc MDT | $80.25 | $74.40 | -7% |
| Boston Scientific Corporation B1SX34 | R$248.75 | R$221.81 | -11% |
| Edwards Lifesciences Corporation EW | $85.88 | $41.02 | -52% |
| Siemens Healthineers AG SEMHF | $40.29 | $47.96 | +19% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is CleanSpace Holdings (CSX) undervalued?
What is the fair value of CSX?
What is the quality score of CSX?
What is the revenue of CleanSpace Holdings (CSX)?
What is the net profit margin of CSX?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.